Cyrille Leperlier
Förmögenhet: - $ per 2024-03-31
Förmögenhet: - $ per 2024-03-31
Cyrille Raymond George Leperlier is currently an Independent Non-Executive Director at NuCana Plc since 2018.
Formerly, the role of Chief Executive Officer was held at Divlal SAS from 2020 to 2022.
The position of Medical Director was held at Rhone-Poulenc Rorer, Inc. Medical Director at Sanofi-Aventis Japan was held from 2014 to 2019.
Education includes graduate and doctorate degrees from the University of Paris Jussieu.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
NUCANA PLC -.--% | 2026-03-18 | 0 ( -.--% ) | - $ | 2024-03-31 |
| Företag | Position | Start |
|---|---|---|
| NUCANA PLC | Direktör/Styrelseledamot | 2018-05-01 |
| Företag | Position | Slut |
|---|---|---|
Divlal SAS | Verkställande Direktör | 2022-11-01 |
Sanofi-Aventis Japan | Teknisk/Vetenskaplig/F&U Direktör | 2019-12-01 |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Teknisk/Vetenskaplig/F&U Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Health Technology |
University of Paris Jussieu
University of Paris Jussieu Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Aventis Japan | |
NuCana Plc
NuCana Plc BiotechnologyHealth Technology Develops and commercializes novel anti-cancer medicines | Health Technology |
Divlal SAS |
Välj din utgåva
All finansiell information anpassad till den nationella nivån